Integrity Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Integrity Advisory's VRTX Position: Q4 2022 in Review
Integrity Advisory reduced its Vertex Pharmaceuticals (VRTX) stake by 34% in Q4 2022, selling an estimated $239K and leaving 1,512 shares worth $437K. The position accounts for 0.4% of the portfolio, ranked #47.
Integrity Advisory first reported a position in VRTX in Q1 2022 and has held it in 4 quarters since. The position peaked at $665K in Q3 2022. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.
- Integrity Advisory held 1,512 shares of Vertex Pharmaceuticals worth $437K as of Q4 2022.
- Integrity Advisory sold 785 Vertex Pharmaceuticals shares in Q4 2022, an estimated $239K.
- Vertex Pharmaceuticals made up 0.4% of Integrity Advisory's portfolio in Q4 2022, its #47 holding.
- Integrity Advisory first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
- Integrity Advisory's Vertex Pharmaceuticals position peaked at $665K in Q3 2022.
- 1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.
Based on Integrity Advisory's 13F filing for Q4 2022, filed 24 Jan 2023.